Blondin Bioscience Overview

  • Founded
  • 2011
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Blondin Bioscience General Information


Developer of a precision clinical diagnostics device designed to facilitate cancer detection and treatment. The company's device measures a nucleic acid biomarker released from dying cancer cells and sends signals when an inadequate decrease in the cell-free telomere level is observed, enabling oncologists to stay updated about cancer test results and offer faster, personalized and cost effective cancer care to patients.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Primary Office
  • 1500 1st Avenue North
  • Suite 31
  • Birmingham, AL 35203
  • United States
+1 (205) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Blondin Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Sep-2020 0000 Completed Out of Business
3. Grant 17-Mar-2017 00000 0000 Completed Startup
2. Grant 05-May-2016 $10K $50K Completed Startup
1. Accelerator/Incubator $50K $50K 00000 Completed Startup
To view Blondin Bioscience’s complete valuation and funding history, request access »